{"id":1424,"date":"2020-02-13T09:39:56","date_gmt":"2020-02-13T09:39:56","guid":{"rendered":"https:\/\/www.ipsen.com\/spain\/?p=1424"},"modified":"2024-12-16T12:25:00","modified_gmt":"2024-12-16T10:25:00","slug":"resultados-anuales-de-ipsen-2019","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/spain\/press-releases\/resultados-anuales-de-ipsen-2019\/","title":{"rendered":"Resultados anuales de Ipsen 2019"},"content":{"rendered":"\n
Par\u00eds (Francia), 13 de febrero de 2019<\/strong>.- Ipsen (Euronext: IPN; ADR: IPSEY), compa\u00f1\u00eda biofarmac\u00e9utica global centrada en innovaci\u00f3n y atenci\u00f3n especializada, presenta sus resultados anuales de 2019, sus estimaciones para 2020 y actualiza sus perspectivas financieras para 2022.<\/p>\n\n\n\n M\u00e1s informaci\u00f3n:<\/strong>\u00a0Ipsen.com<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":11,"template":"","categories":[39],"tags":[],"class_list":["post-1424","press_release","type-press_release","status-publish","hentry","category-notas-de-prensa","entry"],"acf":[],"yoast_head":"\n